RECURRENT LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Clinical trials for RECURRENT LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a drug combo outperform chemo for tough lung cancer?
Disease control OngoingThis study tests whether the drug cabozantinib, alone or combined with the immunotherapy nivolumab, works better than standard chemotherapy for people with advanced non-squamous non-small cell lung cancer that has come back after prior treatment. The trial involves 117 adults wit…
Matched conditions: RECURRENT LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New targeted pill shows promise for Hard-to-Treat lung cancer
Disease control OngoingThis study tests a drug called AMG 510 in people with advanced lung cancer that has a specific genetic change (KRAS G12C mutation). The drug is designed to block the cancer's growth signal. About 116 participants will receive the treatment to see if it shrinks tumors and how safe…
Matched conditions: RECURRENT LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 19, 2026 12:00 UTC